Skip to main content
Download PDF

Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population

BMC Microbiology volume 20, Article number: 221 (2020) Cite this article

Abstract

Background

Gut microbiota plays an important role in physiological and pathological processes of the host organism, including aging. Microbiota composition was shown to vary significantly throughout the life course. Age-related changes in the composition of microbiota were reported in several human studies. In present study, age-related dynamics of phylogenetic profile of gut microbiota was investigated in 1550 healthy participants from Ukrainian population.

Results

Significant changes in the microbiota composition determined by qRT-PCR at the level of major microbial phyla across age groups have been observed. The relative abundance of Actinobacteria and Firmicutes phyla increased, while that of Bacteroidetes decreased from childhood to elderly age. Accordingly, the Firmicutes/Bacteroidetes (F/B) ratio was shown to significantly increase until elder age. In both sexes, odds to have F/B > 1 tended to increase with age, reaching maximum values in elder age groups [OR = 2.7 (95% CI, 1.2–6.0) and OR = 3.7 (95% CI, 1.4–9.6) for female and male 60–69-year age groups, respectively, compared to same-sex reference (0–9-year) age groups].

Conclusions

In conclusion, data from our study indicate that composition of the human intestinal microbiota at the level of major microbial phyla significantly differs across age groups. In both sexes, the F/B ratio tends to increase with age from 0–9-year to 60–69-year age groups. Further studies are needed for a better understanding of mechanisms underlying age-related dynamics of human microbiota composition.

Background

Accumulating evidence indicates that intestinal microbiota (microbial community inhabiting the gut) is crucially involved in the host organism’s vital functions [1]. The crucial role of the gut microbiota and its metabolites in regulating multiple physiological functions of the host is firmly established [2]. In particular, the intestinal microbiota essentially contributes to human metabolism by providing enzymes which are not encoded by the human genome but play important roles in the breakdown of polysaccharides and polyphenols and also in synthesis of vitamins [3]. Disturbances in gastrointestinal physiology mediated by the loss of microbial diversity or changes in relative abundance of the gut microbial communities are commonly referred to as dysbiosis [4]. Such disturbances caused by disease or aging may impair normal nutrient intake and microbiota functions, while changes in microbiota composition may, in turn, significantly contribute to the age-associated functional decline and various pathological conditions [5]. The disruption of the healthy microbial community may cause systemic pathological conditions such as atherosclerosis, type 2 diabetes and cancer [5, 6].

Both composition of gut microbiota and, accordingly, microbiome (collective genomes of all the microbes inhabiting the gastrointestinal tract) were shown to vary significantly throughout the life course [7,8,9]. Available evidence suggests that adult-like composition of gut microbiota is established early in life [10,11,12,13,14]. The microbial composition develops into a quite stable adult-like pattern during the first 2–3 years of the child’s life and remains relatively unchanged across the rest of the human life course [15,16,17]. Unfavorable life events such as diseases, antibiotic treatments and sharp changes in diet may only cause chaotic and transient shifts in diversity, composition and functional features of intestinal microbiome [1]. The most pronounced microbiota changes occur during the transition from adulthood to old age. In elderly (more than 65-year-old) individuals, a reduction in the diversity of microbiome along with greater inter-individual microbiota variations have been observed compared to adult ones [18, 19]. Accumulating evidence from both animal models and human studies indicates that gut microbiota composition plays an important role in the host aging and determines the potential of longevity [8]. In particular, long-term has been shown to promote age-related processes such as systemic inflammation and insulin resistance [20, 21]. The age-related changes in microbiota composition, however, can not necessarily be caused by aging process per se, but they might be also associated with general decline in health status caused by malnutrition or increased need for medications such as non-steroidal anti-inflammatory drugs or antibiotics [18].

The purpose of present study was to investigate whether age-related changes exist in phylogenetic profile of gut microbiota, in particular in the Firmicutes to Bacteroidetes (F/B) ratio, in healthy population of Ukraine. In contrast to previous studies on the topic performed on small-size samples, our study has been performed with a larger sample size (n = 1550), allowing to draw more robust conclusions on the age-related dynamics of microbiota composition.

Results

Significant changes in the gut microbiota composition across age groups have been observed. The relative abundance of Firmicutes phylum tended to increase with age. In the oldest group included in overall analysis (60–69 years), it was 40% higher than in children group (0–9 years) (Table 1). The Bacteroidetes abundance demonstrated the opposite age trend: it was about 80% lower in elderly compared to children. As a result, the F/B ratio tended to increase with age reaching the highest value (1.42) in the 60–69-year age group.

Table 1 Median values and 25/75 percentiles of main microbiota phyla across age groups (mixed sexes)
Full size table

The opposite trend to decrease F/B ratio has been observed in a more advanced age group (70+). This age group was not included in the overall analysis due to its small sample size (n = 19; among them, 8 men and 11 women). In this age group, the F/B ratio was estimated to be 0.87 (IQR: 0.24–1.53). This ratio was significantly lower than that in the eldest (60–69-year) age group included in the overall analysis and did not differ significantly from that in the children’s (0–9-year) group.

The relative abundance of Actinobacteria, similarly to that for Firmicutes, tended to increase with age. This trend, however, was less pronounced than that in Firmicutes. No significant age changes were found for other bacterial groups. Interestingly, the changes observed were quite similar among sexes (see Figs. 1 and 2).

Fig. 1
figure 1

Changes in relative abundance of major gut microbiota phyla across age groups; (a) male; (b) female

Full size image
Fig. 2
figure 2

Relative abundance (%) of major gut microbiota phyla: (a) Actinobacteria (b) Firmicutes, (c) Bacteroidetes, and (d) F/B ratio. Data are given as median values (horizontal lines) with whiskers indicating 95% confidence intervals (CIs). Female, orange; male, black

Full size image

The absence of significant sex effect was further confirmed by logistic regression analysis. In the logistic regression model fitted with age and sex as covariates, no significant association was found between the age and the F/B ratio (Table 2). Accordingly, odds ratios (ORs) to have F/B > 1 tended to increase with age in both sexes, reaching maximum values of 2.7 (95% CI, 1.2–6.0) and 3.7 (95% CI, 1.4–9.6) in female and male 60–69-year age groups, respectively, compared to same-sex reference (0–9-year) age groups (Fig. 3).

Table 2 Logistic regression analysis of association between age and F/B ratio
Full size table
Fig. 3
figure 3

Odds ratios and 95% CIs to have F/B > 1 in males and females from different age groups compared to corresponding reference groups (ORs = 1 in both male and female 0–9-year reference groups). Female, orange; male, black

Full size image

Discussion

Microbiome is undoubtedly an important determinant of many aging-related pathological states. Among them, there are chronic inflammation [22], neurodegeneration [23], sarcopenia [24], osteoporosis [25], obesity, metabolic syndrome and type 2 diabetes [26, 27], cardiovascular disease [28] and cancer [29]. Therefore, age-associated changes in microbiota composition and function seem to be very important in the biogerontological context.

Age-related change in the F/B ratio could be particularly important. Firmicutes and Bacteroidetes are two dominant phyla representing together up to 90% of the total gut microbiota [30]. The F/B ratio has been suggested as an important index of the health of gut microbiota [31]. This ratio is known to be associated with different pathological states including the aging-associated ones [32]. For instance, the association of high F/B ratio with obesity and metabolic syndrome has been observed repeatedly [33]. Mechanistically, it may be also associated with aging-related processes determining human health status. In particular, it has been shown to be significantly associated with production of short chain fatty acids such as butyrate and propionate [34]. These microbiota-generated short chain fatty acids are known to substantially influence human healthspan. In particular, butyrate is important anti-inflammatory molecule acting on both enterocytes and circulating immune cells, thereby regulating gut barrier integrity, while propionate production is of importance for human health since it promotes satiety and prevents hepatic lipogenesis thereby lowering the cholesterol production [35, 36]. Moreover, the increased F/B ratio has been shown to be associated with an increased energy harvest from colonic fermentation [37].

However, even despite the obvious clinical importance of the gut microbiota composition, its age-related dynamics, including dynamics of F/B ratio, was evaluated only in few small-size studies, and only one available study was exclusively focused on the examination of this dynamics [38]. In this research, the F/B ratio was found to sharply increase from infancy to adulthood, and then just as sharply decreased from adulthood to old age. More specifically, F/B ratios were 0.4, 10.9 and 0.6 in infants (3 weeks to 10 months old, n = 21), adults (25–45 y, n = 21) and elderly (70–90 y, n = 20), respectively. In the Korean urbanized town communities, F/B ratio has been shown to be significantly higher in adults (40–69 y, n = 40) than in children (0–8 y, n = 22) [39]. The decrease in relative abundance of Firmicutes and increase in relative abundance of Bacteroidetes have been observed in the elderly (70–85 y, n = 18) compared to young adults (21–39 y, n = 14) [40]. The F/B ratio was also found to be lower in elderly subjects (65 y and older, n = 161) when compared to young adults (28–46 y, n = 9) in the study by Claesson et al. [41]. It has been speculated that such changes in microbiome composition may reflect the gradual decline of organ function and ability to maintain barrier integrity in elderly [42, 43]. In the study by Biagi et al. [44], F/B ratios were estimated as 3.6, 5.1, and 3.9 in young adults (25–40 y, n = 20), elderly (63–76 y, n = 22) and centenarians (99–104 y, n = 21), respectively. The differences among the age groups were, however, not statistically significant. More recently, higher proportions of Bacteroidetes and lower proportions of Firmicutes were observed in centenarians (95–108 y, n = 30) living in Longevity Villages of South Korea compared to those in elderly (67–79 y, n = 17) living in the same villages [45]. Summarizing findings from these studies and comparing them with our results, it can be concluded that our findings corroborate data presented in previous publications. In our study, consistently with previous findings, F/B ratio tended to increase with age from childhood to elderly age. The opposite trend to decrease F/B ratio has been observed in a more advanced age group which were not included in the overall analysis due to its small sample size. Such a small sample size was due to the obvious difficulty in recruiting healthy people that met the criteria for inclusion (e.g., absence of serious health problems or multidrug consumption) among the old elderly.

There are certainly multiple factors contributing to age-related phylogenetic changes in the microbiota composition. Undoubtedly, diet is among the most important factors affecting the composition of the human intestinal microbiome. Indeed, there is convincing evidence that Western-style diet characterized by high intakes of saturated fat and sugar is associated with a Bacteroides-dominant microbiome, while the more traditional high-fiber diet rich in fermented foods, vegetables and fish is associated with a high Firmicutes abundance [46]. Since the last (pro-healthy) dietary pattern is more common in older age groups [47], age-related differences in this pattern may likely explain the trend to increase in the F/B ratio with age observed in our and other studies. Other potential explanations can include influence of hormones such as sex hormones and their changing levels over age [48], impact of immunosenescence and related systemic inflammation (inflamm-aging) [49], and also repeated antibiotic interventions [50]. Moreover, the observed microbiota changes may be likely associated with age-related alterations in body mass index (BMI) found to be steadily raised in various countries across age groups until the early old age (appr. Age 60) and decreased thereafter (see, e.g., ref. [51,52,53,54]). Importantly, the association between BMI and composition of gut microbiota at different taxonomic levels, including the F/B ratio, has been well established in many populations including the Ukrainian one [55]. Therefore, age-related dynamics of BMI could be an important factor affecting the association between age and F/B ratio. Indeed, it can be suggested that age trends in F/B ratio observed in our research and in studies conducted in other populations may mirror respective age trends in BMI. We did not have data on the height and weight for participants of present study. Howerer, given that BMI might be an important confounder of the association between age and F/B ratio, we plan to include such data in our further research.

The primary strength of present study compared with prior studies on the topic is the relatively large sample size. One exception is the oldest age group (70+). The small sample size in this age group allows only preliminary conclusions. Therefore, we plan to recruit more old people for further studies. The other limitation of our research is the cross-sectional design used which did not allow us to draw definitive conclusions regarding the causal relationships between age and gut microbiota composition. One more direction for our future research is to investigate more diverse microbiota taxonomic levels. In present study, we evaluated relative abundances of the most abundant phyla, such as Firmicutes, Bacteroitedes and Actinobacteria, representing about 90% of the total bacterial population in studied sample. It is known, however, that increment in the relative abundance of Gram-negative bacteria such as Proteobacteria is one of the most important detrimental age-related changes in the human gut microbiota composition, since these Gram-negative bacteria secrete lipopolysaccharides that can cause inflammation in the gut [56]. Therefore, we plan to evaluate the relative abundance of Proteobacteria, among other Gram-negative bacteria, in our further studies.

When discussing potential mechanisms contributing to the observed age-related phylogenetic changes in the composition of microbiota, it needs to consider that it is apparently difficult to distinguish correlation from causality in the relationships observed [48]. Indeed, the microbiota and the host influence each other reciprocally, and different constituents of the microbiota interact in various ways among themselves over a human life course. Therefore, more in-depth studies are needed for a better understanding of mechanisms underlying age-related dynamics of human microbiota composition.

Conclusions

In conclusion, data from our study indicate that composition of the human intestinal microbiota at the level of major microbial phyla can significantly differ across age groups. In both sexes, the F/B ratio tended to increase with age from 0 to 9-year to 60–69-year age groups.

Methods

Study population

Fecal samples were obtained from 1550 subjects residing in Ukraine and visited medical clinics in Dnipro and Kyiv for laboratory examinations and consultations throughout the time period from 19 May, 2017 to 16 March, 2020. The main demographic characteristics of the study population are provided in Table 3. Before enrollment, written informed consent has been obtained from each study participant to provide a stool sample and to an availability of stored sample for additional assays. The exclusion criteria were specified as follows: (a) refusal to give an informed consent; (b) serious health problems such as recent surgery, current presence of infectious disease or cancer, types 1 diabetes, mental illness or poorly controlled type 2 diabetes; (c) consumption of prebiotics, probiotics and antibiotics within 3 months before the enrollment date.

Table 3 Basic characteristics of the study population
Full size table

Sample collection and DNA extraction

Fresh stool samples have been provided once by each of the study participants in a stool container on site. All fecal samples were collected and frozen immediately upon defecation. The collected samples were stored at −20 °C for about 1 week until DNA isolation. DNA was extracted from frozen aliquot (100 mg) of fecal sample using the phenol-chloroform method by protocol provided by Zhang et al. [57]. DNA samples have been stored in elution buffer (200 μl per sample). The DNA quality and quantity were evaluated by NanoDrop ND-8000 (Thermo Scientific, USA). Solutions containing DNA concentration less than 20 ng and/or an A 260/280 less than 1.8 were subjected to an ethanol precipitation to meet the quality standards.

PCR amplification

PCR reactions were conducted using a real-time thermal cycler Rotor-Gene 6000 (QIAGEN, Germany) as described previously [55] with modifications. Conditions of PCR reaction were as follows: an initial denaturation for 5 min at 95 °C, 30 cycles of 95 °C for 15 s, annealing (15 s at 61.5 °C and 72 °C at 30 s), and then a final elongation at 72 °C for 5 min. Every PCR reaction contained 0.05 units/μl of Taq polymerase (Sigma Aldrich), 0.2 mM of each dNTP, 0.4 μM of each primer, 1× buffer, ~ 10 ng of DNA and water to 25 μl. All samples have been amplified with all primer pairs in triplicates. The Cts (both universal and specific) were the threshold cycles registered by the thermocycler. The average Ct values obtained for each pair have been transformed into percentages by the formula provided by Bacchetti De Gregoris et al. [58]:

$$ \mathrm{X}={\left(\mathrm{Eff}.\kern0.5em \mathrm{Univ}\right)}^{{\mathrm{Ct}}_{\mathrm{univ}}}/{\left(\mathrm{Eff}.\kern0.5em \mathrm{Spec}\right)}^{{\mathrm{Ct}}_{\mathrm{spec}}}\ast 100, $$

where Cts (both universal and specific) are the threshold cycles registered by the thermocycler. Eff. Univ refers to the calculated efficiency of universal primers (2 = 100% and 1 = 0%) and Eff. Spec is the efficiency of the taxon-specific primers. According to the equation, X represents the percentage of 16S taxon-specific copy number in a given sample. The detection of qPCR amplification products was based on the fluorescence of SYBR Green dye. The qPCR amplification efficiency was determined using multiple dilution series.

Identification of the gut microbiota composition at the phylum level

Determination of microbiota composition at the level of major bacterial phyla was performed with quantitative real-time PCR (qRT-PCR) by a method described by Bacchetti De Gregoris et al. [56] using universal primers targeting bacterial 16S rRNA gene, as well as primers specific for Actinobacteria, Firmicutes and Bacteroidetes. All these primers were taken from the Bacchetti De Gregoris et al. [58] article. The primer sequences used are presented in Table 4.

Table 4 Primer nucleotide sequences used for qRT-PCR assay
Full size table

Statistical analysis

All statistical analyses were performed with the MedCalc statistical software version 19.2 (MedCalc Software Inc., Broekstraat, Belgium, 1993–2020). The normality of the distribution of quantitative variables was assessed by Shapiro–Wilk test. The variables studied did not follow a normal distribution, so non-parametric methods were applied in analyses. Numerical data have been expressed as medians and interquartile ranges (25th to 75th percentiles) or 95% confidence intervals (CIs), as appropriate. To identify the statistical difference among age groups, median abundances of each phylum have been compared by Kruskal-Wallis test. Pairwise multiple comparisons between groups were performed by post-hoc Dunn’s test. A multivariate logistic regression analysis has been applied to estimate the effects of age and sex on F/B ratio. Odds ratios (ORs) and corresponding 95% CIs were also calculated from the logistic regression model. The significance threshold was set at p < 0.01.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

F/B ratio:

Firmicutes to Bacteroidetes ratio

IQR:

Interquartile range

GWAS:

Genome-wide association study

OR:

Odds ratio

qRT-PCR:

Real-time polymerase chain reaction

References

  1. Thursby E, Juge N. Introduction to the human gut microbiota. Biochem J. 2017;474(11):1823–36.

    PubMed  CAS  Google Scholar 

  2. Kho ZY, Lal SK. The human gut microbiome – a potential controller of wellness and disease. Front Microbiol. 2018;9:1835.

    PubMed  PubMed Central  Google Scholar 

  3. Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57(1):1–24.

    PubMed  CAS  Google Scholar 

  4. Wilkins LJ, Monga M, Miller AW. Defining dysbiosis for a cluster of chronic diseases. Sci Rep. 2019;9(1):12918.

    PubMed  PubMed Central  Google Scholar 

  5. Finlay BB, Pettersson S, Melby MK, et al. The microbiome mediates environmental effects on aging. Bioessays. 2019;41(10):e1800257.

    PubMed  Google Scholar 

  6. Feng Q, Chen WD, Wang YD. Gut microbiota: an integral moderator in health and disease. Front Microbiol. 2018;9:151.

    PubMed  PubMed Central  Google Scholar 

  7. Nagpal R, Mainali R, Ahmadi S, et al. Gut microbiome and aging: physiological and mechanistic insights. Nutr Healthy Aging. 2018;4(4):267–85.

    PubMed  PubMed Central  Google Scholar 

  8. Aleman FDD, Valenzano DR. Microbiome evolution during host aging. PLoS Pathog. 2019;15(7):e1007727.

    PubMed  PubMed Central  CAS  Google Scholar 

  9. Xu C, Zhu H, Qiu P. Aging progression of human gut microbiota. BMC Microbiol. 2019;19(1):236.

    PubMed  PubMed Central  Google Scholar 

  10. Cukrowska B. Microbial and nutritional programming–the importance of the microbiome and early exposure to potential food allergens in the development of allergies. Nutrients. 2018;10(10):1541.

    PubMed Central  Google Scholar 

  11. McCoy KD, Thomson CA. The impact of maternal microbes and microbial colonization in early life on hematopoiesis. J Immunol. 2018;200(8):2519–26.

    PubMed  CAS  Google Scholar 

  12. Robertson RC, Manges AR, Finlay BB, et al. The human microbiome and child growth – first 1000 days and beyond. Trends Microbiol. 2019;27(2):131–47.

    PubMed  CAS  Google Scholar 

  13. Walker RW, Clemente JC, Peter I, et al. The prenatal gut microbiome: are we colonized with bacteria in utero? Pediatr Obes. 2017;12(Suppl 1):3–17.

    PubMed  PubMed Central  Google Scholar 

  14. Milani C, Duranti S, Bottacini F, Casey E, et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev. 2017;81(4):e00036–17.

    PubMed  PubMed Central  Google Scholar 

  15. Koleva PT, Kim JS, Scott JA, et al. Microbial programming of health and disease starts during fetal life. Birth Defects Res C Embryo Today. 2015;105(4):265–77.

    PubMed  CAS  Google Scholar 

  16. Zhuang L, Chen H, Zhang S, Zhuang J, Li Q, Feng Z. Intestinal microbiota in early life and its implications on childhood health. Genomics Proteomics Bioinformatics. 2019;17(1):13–25.

    PubMed  PubMed Central  Google Scholar 

  17. Fouhy F, Watkins C, Hill CJ, et al. Perinatal factors affect the gut microbiota up to four years after birth. Nat Commun. 2019;10(1):1517.

    PubMed  PubMed Central  Google Scholar 

  18. Rondanelli M, Giacosa A, Faliva MA, et al. Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases. 2015;3(2):156–62.

    PubMed  PubMed Central  Google Scholar 

  19. Lu M, Wang Z. Microbiota and aging. Adv Exp Med Biol. 2018;1086:141–56.

    PubMed  CAS  Google Scholar 

  20. Clemente JC, Manasson J, Scher JU. The role of the gut microbiome in systemic inflammatory disease. BMJ. 2018;360:j5145.

    PubMed  PubMed Central  Google Scholar 

  21. Lee CJ, Sears CL, Maruthur N. Gut microbiome and its role in obesity and insulin resistance. Ann N Y Acad Sci. 2020;1461:37–52.

    PubMed  Google Scholar 

  22. Blander JM, Longman RS, Iliev ID, et al. Regulation of inflammation by microbiota interactions with the host. Nat Immunol. 2017;18(8):851–60.

    PubMed  PubMed Central  CAS  Google Scholar 

  23. Roy Sarkar S, Banerjee S. Gut microbiota in neurodegenerative disorders. J Neuroimmunol. 2019;328:98–104.

    PubMed  CAS  Google Scholar 

  24. Ticinesi A, Nouvenne A, Cerundolo N, et al. Gut microbiota, muscle mass and function in aging: a focus on physical frailty and sarcopenia. Nutrients. 2019;11(7):1633.

    PubMed Central  CAS  Google Scholar 

  25. Yatsonsky Ii D, Pan K, Shendge VB, et al. Linkage of microbiota and osteoporosis: a mini literature review. World J Orthop. 2019;10(3):123–7.

    PubMed  PubMed Central  Google Scholar 

  26. Chen X, Devaraj S. Gut microbiome in obesity, metabolic syndrome, and diabetes. Curr Diab Rep. 2018;18:129.

    PubMed  CAS  Google Scholar 

  27. Singer–Englar T, Barlow G, Mathur R. Obesity, diabetes, and the gut microbiome: an updated review. Expert Rev Gastroenterol Hepatol. 2019;13:3–15.

    PubMed  Google Scholar 

  28. Jin M, Qian Z, Yin J, et al. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med. 2019;23(4):2343–50.

    PubMed  PubMed Central  Google Scholar 

  29. Vivarelli S, Salemi R, Candido S, et al. Gut microbiota and cancer: from pathogenesis to therapy. Cancers (Basel). 2019;11(1):38.

    CAS  Google Scholar 

  30. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.

    Google Scholar 

  31. Li W, Ma ZS. FBA ecological guild: trio of Firmicutes–Bacteroidetes alliance against Actinobacteria in human oral microbiome. Sci Rep. 2020;10:287.

    PubMed  PubMed Central  CAS  Google Scholar 

  32. Liang D, Leung RK, Guan W, et al. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog. 2018;10:3.

    PubMed  PubMed Central  Google Scholar 

  33. Woting A, Blaut M. The intestinal microbiota in metabolic disease. Nutrients. 2016;8(4):202.

    PubMed  PubMed Central  Google Scholar 

  34. Fernandes J, Su W, Rahat–Rozenbloom S, et al. Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans. Nutr Diabetes. 2014;4:e121.

    PubMed  PubMed Central  CAS  Google Scholar 

  35. Bifari F, Ruocco C, Decimo I, et al. Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control. Genes Nutr. 2017;12:27.

    PubMed  PubMed Central  Google Scholar 

  36. Chambers ES, Preston T, Frost G, et al. Role of gut microbiota–generated short–chain fatty acids in metabolic and cardiovascular health. Curr Nutr Rep. 2018;7:198–206.

    PubMed  PubMed Central  CAS  Google Scholar 

  37. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity–associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.

    PubMed  Google Scholar 

  38. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009;9:123.

    PubMed  PubMed Central  CAS  Google Scholar 

  39. Park SH, Kim KA, Ahn YT, et al. Comparative analysis of gut microbiota in elderly people of urbanized towns and longevity villages. BMC Microbiol. 2015;15:49.

    PubMed  PubMed Central  Google Scholar 

  40. Mäkivuokko H, Tiihonen K, Tynkkynen S, et al. The effect of age and non–steroidal anti–inflammatory drugs on human intestinal microbiota composition. Br J Nutr. 2010;103:227–34.

    PubMed  Google Scholar 

  41. Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4586–91.

    PubMed  CAS  Google Scholar 

  42. Kundu P, Blacher E, Elinav E, et al. Our gut microbiome: the evolving inner self. Cell. 2017;171:1481–93.

    PubMed  CAS  Google Scholar 

  43. Reza MM, Finlay BB, Pettersson S. Gut microbes, ageing & organ function: a chameleon in modern biology? EMBO Mol Med. 2019;11:e9872.

    PubMed  PubMed Central  Google Scholar 

  44. Biagi E, Nylund L, Candela M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010;5:e10667.

    PubMed  PubMed Central  Google Scholar 

  45. Kim BS, Choi CW, Shin H, et al. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups. J Microbiol Biotechnol. 2019;29:429–40.

    PubMed  Google Scholar 

  46. Wu GD, Chen J, Hoffmann C, et al. Linking long–term dietary patterns with gut microbial enterotypes. Science. 2011;334:105–8.

    PubMed  PubMed Central  CAS  Google Scholar 

  47. Inelmen EM, Toffanello ED, Enzi G, et al. Differences in dietary patterns between older and younger obese and overweight outpatients. J Nutr Health Aging. 2008;12:3–8.

    PubMed  CAS  Google Scholar 

  48. Saraswati S, Sitaraman R. Aging and the human gut microbiota–from correlation to causality. Front Microbiol. 2015;5:764.

    PubMed  PubMed Central  Google Scholar 

  49. Fulop T, Larbi A, Dupuis G, et al. Immunosenescence and inflamm–aging as two sides of the same coin: friends or foes? Front Immunol. 2018;8:1960.

    PubMed  PubMed Central  Google Scholar 

  50. Zimmermann P, Curtis N. The effect of antibiotics on the composition of the intestinal microbiota – a systematic review. J Inf Secur. 2019;79:471–89.

    Google Scholar 

  51. Wilson R, Abbott JH. Age, period and cohort effects on body mass index in New Zealand, 1997–2038. Aust N Z J Public Health. 2018;42:396–402.

    PubMed  Google Scholar 

  52. Perissinotto E, Pisent C, Sergi G, Grigoletto F, ILSA Working Group (Italian Longitudinal Study on Ageing). Anthropometric measurements in the elderly: age and gender differences. Br J Nutr. 2002;87:177–86.

    PubMed  CAS  Google Scholar 

  53. Frenzel A, Binder H, Walter N, Wirkner K, Loeffler M, Loeffler-Wirth H. The aging human body shape. NPJ Aging Mech Dis. 2020;6:5.

    PubMed  PubMed Central  Google Scholar 

  54. Livshits G, Malkin I, Williams FM, Hart DJ, Hakim A, Spector TD. Longitudinal study of variation in body mass index in middle-aged UK females. Age (Dordr). 2012;34(5):1285–94.

    Google Scholar 

  55. Koliada A, Syzenko G, Moseiko V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiol. 2017;17:120.

    PubMed  PubMed Central  Google Scholar 

  56. Kumar M, Babaei P, Ji B, Nielsen J. Human gut microbiota and healthy aging: recent developments and future prospective. Nutr Healthy Aging. 2016;4(1):3–16.

    PubMed  PubMed Central  Google Scholar 

  57. Zhang BW, Li M, Ma LC, et al. A widely applicable protocol for DNA isolation from fecal samples. Biochem Genet. 2006;44:503–12.

    PubMed  CAS  Google Scholar 

  58. Bacchetti De Gregoris T, Aldred N, Clare AS, et al. Improvement of phylum– and class–specific primers for real–time PCR quantification of bacterial taxa. J Microbiol Methods. 2011;86:351–6.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We would like to thank all the participants for agreeing to participate in the study and staff of the Institute of Gerontology, Molecular Genetic Laboratory Diagen and PB MEDICOM-IN for help in collecting and processing stool samples. We also thank Alina Zayachkivska for technical assistance in the preparation of the manuscript.

Funding

No funds were received from governmental or private agencies to conduct this study.

Author information

Authors and Affiliations

  1. Institute of Gerontology, Vyshgorodskaya st. 67, Kyiv, 04114, Ukraine

    Alexander Vaiserman, Mariana Romanenko, Liubov Piven & Alexander Koliada

  2. Molecular Genetic Laboratory Diagen, Kyiv, Ukraine

    Vladislav Moseiko

  3. Vasyl Stefanyk Precarpathian National University, Ivano-Frankivsk, Ukraine

    Oleh Lushchak

  4. PB MEDICOM-IN, Dnipro, Ukraine

    Nadiia Kryzhanovska

  5. Bogomolets National Medical University, Kyiv, Ukraine

    Vitaly Guryanov

Authors
  1. Alexander Vaiserman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariana Romanenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liubov Piven
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vladislav Moseiko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Oleh Lushchak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nadiia Kryzhanovska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vitaly Guryanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alexander Koliada
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conception and design of the study: AV, OL and AK. Collection of data: MR, LP, NK and VM. Analysis and interpretation of data: AV, LP, OL, VG and AK. Manuscript drafting: AV and AK. Study supervision and administrative support: AK, NK and MR. All authors read, revised and approved the final draft.

Corresponding author

Correspondence to Alexander Vaiserman.

Ethics declarations

Ethics approval and consent to participate

Written informed consents to provide a stool sample and to the availability of the stored samples for additional bioassays have been obtained from all adult study participants and from parents or guardians for participants under 16 years old before enrollment. The study has been conducted in accordance with the Declaration of Helsinki and approved by Ethics Committee of the Kyiv Institute of Gerontology (approval number: 88/16; date of approval: 28/12/2016).

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vaiserman, A., Romanenko, M., Piven, L. et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol 20, 221 (2020). https://doi.org/10.1186/s12866-020-01903-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12866-020-01903-7

Keywords

  • Gut microbiota composition
  • Firmicutes/Bacteroidetes ratio
  • Aging
  • Age-related changes

BMC Microbiology

ISSN: 1471-2180

Contact us